SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study).
Ryan D Hirsch, Chris Mills, Rohit Sawhney, Siddharth Sood, Virginia Bird, Gauri Mishra, Anouk Dev, William Kemp, John Lubel, Stuart K Roberts, Paul Gow, Amanda J Nicoll
J Gastrointest Cancer | Published : 2021
BACKGROUND: Hepatocellular carcinoma (HCC) is responsible for 1% of deaths worldwide, and the incidence continues to increase. Despite surveillance programs, 70% of HCC patients are not suitable for curative options at diagnosis, and therefore, non-curative treatments are essential to modern clinical practice. There are many novel treatments, though their roles are not well defined. This study aimed to contrast Selective Internal Radiation Therapy (SIRT) and Drug Eluting Bead Transarterial Chemoembolisation (DEB-TACE) to further define their roles. METHODS: This was a retrospective multicentre cohort study. Factors included for analysis were type of HCC treatment, number of lesions, lesion s..View full abstract